Xenon Pharmaceuticals Inc (XENE)
42.94
-0.02
(-0.06%)
USD |
NASDAQ |
Mar 28, 11:55
Xenon Pharmaceuticals Cash from Investing (TTM): -117.17M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -117.17M |
September 30, 2023 | 108.22M |
June 30, 2023 | -173.91M |
March 31, 2023 | -200.49M |
December 31, 2022 | -296.00M |
September 30, 2022 | -497.10M |
June 30, 2022 | -247.43M |
March 31, 2022 | -240.55M |
December 31, 2021 | -246.77M |
September 30, 2021 | 11.86M |
June 30, 2021 | -21.74M |
March 31, 2021 | -19.00M |
December 31, 2020 | -16.82M |
September 30, 2020 | -120.34M |
June 30, 2020 | -94.57M |
March 31, 2020 | -112.13M |
December 31, 2019 | -66.21M |
September 30, 2019 | -18.45M |
June 30, 2019 | -49.54M |
Date | Value |
---|---|
March 31, 2019 | -40.97M |
December 31, 2018 | -28.99M |
September 30, 2018 | -10.63M |
June 30, 2018 | 12.63M |
March 31, 2018 | 20.02M |
December 31, 2017 | 24.29M |
September 30, 2017 | -13.74M |
June 30, 2017 | -13.76M |
March 31, 2017 | -38.51M |
December 31, 2016 | -47.84M |
September 30, 2016 | -15.76M |
June 30, 2016 | -6.939M |
March 31, 2016 | 8.62M |
December 31, 2015 | 10.19M |
September 30, 2015 | 11.38M |
June 30, 2015 | -2.741M |
March 31, 2015 | -1.415M |
December 31, 2014 | -3.244M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-497.10M
Minimum
Sep 2022
108.22M
Maximum
Sep 2023
-122.96M
Average
-103.35M
Median
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1748M |
ESSA Pharma Inc | 6.200M |